Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

Authors: de la Rubia, Javier, González, Bernardo, Cruz-Jentoft, Alfonso J., Iglesias, Lorena, Jarque, Isidro, Persona, Ernesto Pérez, Lluch, Rafael, Marrero, Carmen, Zudaire, Maite, Gironella, Mercedes, Hernández-Rivas, José Ángel, Arnan, Montserrat, Olivier, Carmen, Encinas, Cristina, Soler, Juan Alfonso, Payer, Ángel Ramírez, Casado, Alfonso, Fernández, Patricia, Vilanova, David, Bonanad, Santiago

Source: In Journal of Geriatric Oncology January 2023 14(1)

Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.

Authors: Pérez-Lamas, Lucía, de Paz Arias, Raquel, Díaz, Rosa Mª Ayala, Montero, Luis Felipe Casado, Payer, Ángel Ramírez, Sierra, Magdalena, Marín, Francisca Ferrer, López, Raúl Pérez, Cirici, Blanca Xicoy, Steegmann, Juan Luis, Gómez Casares, María Teresa, Martínez-López, Joaquín, García-Gutiérrez, Valentín

Source: Annals of Hematology; Oct2024, Vol. 103 Issue 10, p4045-4055, 11p

Subject Terms: CHRONIC myeloid leukemia, TERMINATION of treatment, ALKALINE phosphatase, THERAPEUTICS, ATEZOLIZUMAB

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients

Authors: García-Gutiérrez, Valentín, Milojkovic, Dragana, Hernandez-Boluda, Juan Carlos, Claudiani, Simone, Martin Mateos, María Luisa, Casado-Montero, Luis Felipe, González, Gloria, Jimenez-Velasco, Antonio, Boque, Concepcion, Martinez-Trillos, Alejandra, Vázquez, Isabel Mata, Payer, Ángel Ramírez, Senín, Alicia, Amustio Díez, Elena, García, Abelardo Bárez, Carrascosa, Guiomar Bautista, Ortí, Guillermo, Ruiz, Beatriz Cuevas, Fernández, Maria Ángeles, del Carmen García Garay, María, Giraldo, Pilar, Guinea, Jose María, De Las Heras Rodríguez, Natalia, Hernán, Nuria, Pérez, Ana Iglesias, Piris-Villaespesa, Miguel, Lorenzo, Jose Luis López, Martí-Tutusaus, Josep Maria Martí, Vallansot, Rolando Omar, Ortega Rivas, Fernando, Puerta, Jose Manuel, Ramirez, Maria Jose, Romero, Esperanza, Romo, Andres, Rosell, Ana, Saavedra, Silvanna Saavedra, Sebrango, Ana, Tallon, José, Valencia, Sandra, Portero, Angeles, Steegmann, Juan Luis

Source: Annals of hematology. 98(2):321-330

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125400208.0x000001&indx=1&recIds=ETOCvdc_100125400208.0x000001

P-164: Safety of lenalidomide (LEN)-based therapy vs non–LEN-based therapy for transplant-ineligible newly diagnosed multiple myeloma (TNE NDMM): update from the post-authorization study MM-034

Authors: Gamberi, Barbara, De Stefano, Valerio, Payer, Angel Ramirez, Wiesholzer, Martin, Tromp, Yvonne, Perera, Meegahage Ratnakanthi, Richez-Olivier, Valentine, Dhanasiri, Sujith, Rosettani, Barbara, York, Jelena, Cavo, Michele

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2021 21 Supplement 2:S125-S126

Outcome of first-line therapy in patients with systemic light-chain amyloidosis: A multicentre analysis

Authors: Fernández, Rubén, Silva - Soto, Ana, Muñiz, Sara, Gonzalez, Ana Pilar, Payer, Angel Ramirez, Bermudez, Arancha, Taboada, Francisco, Chamorro, Cristina, Moran, Marlen, Robles, Verónica, Sanchez, Sara, Torres, Juan, Dominguez, Francisco, Davalos, Carlos Alberto, Alvarez, Alba, Gonzalez, Segundo, Cepeda, Javier, Fernández, Carmen, González, Esther

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e333-e334

European Post-Authorization Safety Study of Patients With Relapsed or Refractory Multiple Myeloma Treated With Pomalidomide in a Real-World Setting

Authors: Gamberi, Barbara, Albildgaard, Niels, Vekemans, Marie-Christiane, Payer, Angel Ramirez, Kyriakou, Charalampia, Di Raimondo, Francesco, Kueenburg, Elisabeth, Di Micco, Antonia, Rosettani, Barbara, Atiba-Davies, Margaret, Bacon, Pamela, Plesner, Torben

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e256-e256

Prescription Patterns and Outcomes of First-Line Therapy for Non-Transplant Eligible Multiple Myeloma Real-Life Patients According to Age: A Retrospective Analysis of the 2012-2016 Period

Authors: Cejalvo, María José, Bustamante, Gabriela, González, Esther, Vázquea-Álvarez, Judith, García, Ricarda, Payer, Angel Ramirez, Pérez-Persona, Ernesto, Abella, Eugenia, Lopez, Sebastian Garzon, Guiñon, Antonio Garcia, Jarque, Isidro, Gonzalez, Marta S., Sampol, Antonia, Motllo, Cristina, Martí, Josep Maria, Alcalá, Magdalena, Duro, Rafael, Gonzalez, Yolanda, Sastre, Jose Luís, Sarrá, Josep, Lostanau, Giselle, López, Rocío, Rubia, Javier De La

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e237-e238

Post-Authorization Safety Study of Lenalidomide-Based vs Non–Lenalidomide-Based Treatment in Transplant-Ineligible Newly Diagnosed Multiple Myeloma

Authors: Cavo, Michele, De Stefano, Valerio, Payer, Angel Ramirez, Bilgin, Yavuz, Pichler, Petra, Ziske, Carsten, Kueenburg, Elisabeth, Di Micco, Antonia, Rosettani, Barbara, Pozzi, Stefano, Bacon, Pamela, Gamberi, Barbara

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e226-e227

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.

Authors: On behalf of Grupo Español de Leucemia Mieloide Crónica (GELMC), Grupo Español de Leucemia Mieloide Crónica (GELMC), García-Gutiérrez, Valentín, Piris-Villaespesa, Miguel, Vázquez, Isabel Mata, Payer, Ángel Ramírez, Senín, Alicia, Amustio Díez, Elena, García, Abelardo Bárez, Carrascosa, Guiomar Bautista, Ortí, Guillermo, Ruiz, Beatriz Cuevas, Fernández, Maria Ángeles, Romo, Andres, del Carmen García Garay, María, Milojkovic, Dragana, Claudiani, Simone, Giraldo, Pilar, Guinea, Jose María, De Las Heras Rodríguez, Natalia

Source: Annals of Hematology; Feb2019, Vol. 98 Issue 2, p321-330, 10p

Subject Terms: AMINES, CLINICAL trials, COMPARATIVE studies, LONGITUDINAL method, RESEARCH methodology, MEDICAL cooperation, ORGANIC compounds, PROGNOSIS, QUINOLINE, RESEARCH, EVALUATION research, CHRONIC myeloid leukemia, RETROSPECTIVE studies

This result is not displayed to guests.
Login for full access.

European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety In Patients (Pts) Treated With Pomalidomide (POM)

Authors: Di Raimondo, Francesco, Kyriakou, Charalampia, Schmidt-Hieber, Martin, Vekemans, Marie-Christiane, Payer, Angel Ramirez, Bentsen, Pal Tore, Lauri, Birgitta, Kueenburg, Elisabeth, Atiba-Davies, Margaret, Lersch, Frederik, Rosettani, Barbara, Bacon, Pamela, Plesner, Torben

Source: In Clinical Lymphoma Myeloma and Leukemia February 2017 17(1) Supplement:e62-e62

This result is not displayed to guests.
Login for full access.

Very Early Molecular Responses During The First Two Months Of Therapy Are Highly Predicitive Of Deep Molecular Responses In Newly-Diagnosed Chronic Myeloid Leukemia In Chronic Phase( CML-CP) Patients Treated Upfront With Nilotinib. The Spanish Substudy Of The ENEST1st Trial

Authors: Steegmann, Juan Luis, Casado Montero, Luis Felipe, Gomez-Casares, Maria Teresa ^*, Rozman, Maria ^*, Echeveste, Maria Asunción ^*, Garcia-Gutierrez, J Valentin ^*, Sastre, Jose Luis ^*, Payer, Angel Ramirez ^*, Olavarria, Eduardo ^*, Vall, Ferran ^*, Xicoy, Blanca ^*, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando Omar ^*, Lopez-Lorenzo, Jose Luis ^*, Palomera, Luis ^*, Ruiz, Soraya ^*, Casas, Laura ^*, Walasek, Claudia ^*, Colomer, Dolors ^*

Source: In Blood 15 November 2013 122(21):5190-5190

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Trisomy 10 in acute myeloid leukemia: Report of a new case

Authors: Luño, Elisa, Payer, Angel Ramirez, Luengo, Jorge Rodriguez, Del Castillo, Teresa Bernal, Garcia, Vicente Pinto

Source: In Cancer Genetics and Cytogenetics 1998 100(1):84-87